NLTX Annual Accounts Receivable
N/A
31 December 2022
Summary:
NLTX annual accounts receivable is not available.NLTX Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NLTX Quarterly Accounts Receivable
N/A
30 September 2023
Summary:
NLTX quarterly accounts receivable is not available.NLTX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NLTX Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
NLTX Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Neoleukin Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $236.00 K(-81.5%) |
| Sept 2019 | - | $1.28 M(+150.7%) |
| June 2019 | - | $509.00 K(-23.1%) |
| Mar 2019 | - | $662.00 K(+179.3%) |
| Dec 2018 | $237.00 K(-68.0%) | $237.00 K(-57.8%) |
| Sept 2018 | - | $562.00 K(-49.1%) |
| June 2018 | - | $1.10 M(-29.4%) |
| Mar 2018 | - | $1.56 M(+111.2%) |
| Dec 2017 | $740.00 K(+73.7%) | $740.00 K(-15.7%) |
| Sept 2017 | - | $878.00 K(-4.0%) |
| June 2017 | - | $915.00 K(+7.0%) |
| Mar 2017 | - | $855.00 K(+100.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | $426.00 K(+35.7%) | $426.00 K(-37.0%) |
| Sept 2016 | - | $676.00 K(-38.0%) |
| June 2016 | - | $1.09 M(+41.2%) |
| Mar 2016 | - | $772.00 K(+145.9%) |
| Dec 2015 | $314.00 K(+383.1%) | $314.00 K(+1552.6%) |
| Sept 2015 | - | $19.00 K(-73.6%) |
| June 2015 | - | $72.00 K(+26.3%) |
| Mar 2015 | - | $57.00 K(-12.3%) |
| Dec 2014 | $65.00 K | $65.00 K(-14.7%) |
| Sept 2014 | - | $76.20 K(+128.1%) |
| June 2014 | - | $33.40 K(-49.8%) |
| Mar 2014 | - | $66.50 K |
FAQ
- What is the all time high annual accounts receivable for Neoleukin Therapeutics?
- What is the all time high quarterly accounts receivable for Neoleukin Therapeutics?
What is the all time high annual accounts receivable for Neoleukin Therapeutics?
Neoleukin Therapeutics all-time high annual accounts receivable is $740.00 K
What is the all time high quarterly accounts receivable for Neoleukin Therapeutics?
Neoleukin Therapeutics all-time high quarterly accounts receivable is $1.56 M